In recent years, semaglutide has emerged as a breakthrough medication in the treatment of type 2 diabetes, obesity, and even heart health. This injectable medication belongs to the GLP-1 receptor agonists class, which works by mimicking the glucagon-like peptide-1 (GLP-1) hormone that plays a significant role in blood sugar control, https://kylerqshaw.blogchaat.com/31037360/semaglutide-transforming-the-treatment-of-diabetes-weight-loss-and-heart-health